Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,637 $ 24,494
Short-term investments 0 6,621
Accounts receivable, net 10,213 9,583
Inventories, net 61,976 60,816
Contract assets 4,032 7,510
Prepaid expenses and other current assets 1,934 4,000
Total current assets 79,792 113,024
Property and equipment, net 13,152 16,326
Equipment on lease, net 3,783 6,667
Other assets 14,060 17,782
Total assets 110,787 153,799
Current liabilities:    
Accounts payable 17,673 15,854
Accrued expenses and other current liabilities 5,325 6,491
Debt – current portion 29,602 21,191
Contract liabilities 10,802 5,135
Total current liabilities 63,402 48,671
Long-term debt – less current portion 0 11,941
Contingent earnout liabilities 11 1,456
Warrant liabilities 2,350 11,835
Other noncurrent liabilities 10,337 11,556
Total liabilities 76,100 85,459
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at September 30, 2024 and December 31, 2023, 9,647,652 and 7,502,478 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 2 2
Additional paid-in capital 443,066 425,471
Accumulated other comprehensive loss 0 (96)
Accumulated deficit (408,381) (357,037)
Total stockholders’ equity 34,687 68,340
Total liabilities and stockholders’ equity $ 110,787 $ 153,799